HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yung-Luen Yu Selected Research

Neoplasms (Cancer)

8/2021The Function of the Mutant p53-R175H in Cancer.
4/2021Praeruptorin A reduces metastasis of human hepatocellular carcinoma cells by targeting ERK/MMP1 signaling pathway.
1/2021Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells.
7/2020Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells.
4/2020Salvianolic acid A suppresses MMP-2 expression and restrains cancer cell invasion through ERK signaling in human nasopharyngeal carcinoma.
1/2020Anti-cancer therapeutic benefit of red guava extracts as a potential therapy in combination with doxorubicin or targeted therapy for triple-negative breast cancer cells.
1/2020α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis.
3/2019Anticancer effects of methotrexate in combination with α‑tocopherol and α‑tocopherol succinate on triple‑negative breast cancer.
1/2019Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells.
1/2018Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yung-Luen Yu Research Topics

Disease

39Neoplasms (Cancer)
08/2021 - 05/2009
13Breast Neoplasms (Breast Cancer)
03/2019 - 12/2006
11Hepatocellular Carcinoma (Hepatoma)
04/2021 - 02/2010
9Triple Negative Breast Neoplasms
01/2021 - 01/2013
5Neoplasm Metastasis (Metastasis)
04/2021 - 04/2013
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 05/2009
4Lung Neoplasms (Lung Cancer)
01/2017 - 05/2009
4Glioblastoma (Glioblastoma Multiforme)
06/2015 - 08/2008
3Brain Neoplasms (Brain Tumor)
06/2015 - 08/2008
3Stroke (Strokes)
10/2013 - 04/2013
2Wounds and Injuries (Trauma)
04/2020 - 01/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2020 - 06/2015
2Rheumatoid Arthritis
04/2017 - 09/2014
2Prostatic Neoplasms (Prostate Cancer)
06/2015 - 07/2014
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2015 - 07/2014
2Pneumonia (Pneumonitis)
04/2014 - 09/2013
2Chronic Hepatitis B
01/2014 - 01/2012
1Nasopharyngeal Carcinoma
04/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2019
1Cough
01/2018
1Chondrosarcoma
01/2018
1Glioma (Gliomas)
01/2018
1Pain (Aches)
01/2018
1Skin Neoplasms (Skin Cancer)
01/2017
1IGA Glomerulonephritis (IGA Nephropathy)
01/2017
1Mouth Neoplasms (Oral Cancer)
05/2016
1Leukemia
06/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2015

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
08/2021 - 05/2012
5ErbB Receptors (EGF Receptor)IBA
07/2014 - 07/2009
4Pharmaceutical PreparationsIBA
01/2021 - 09/2014
4MicroRNAs (MicroRNA)IBA
07/2020 - 12/2013
4Estrogen ReceptorsIBA
01/2020 - 03/2011
4human ERBB2 proteinIBA
01/2020 - 04/2013
4Ribonucleases (Ribonuclease)IBA
06/2015 - 03/2011
3Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 11/2013
3Methotrexate (Mexate)FDA LinkGeneric
03/2019 - 09/2014
3Histones (Histone)IBA
01/2018 - 07/2014
3Matrix Metalloproteinases (MMPs)IBA
01/2018 - 09/2013
3Peptides (Polypeptides)IBA
01/2017 - 01/2013
3Messenger RNA (mRNA)IBA
01/2014 - 04/2011
3Interleukin-15 (Interleukin 15)IBA
05/2012 - 05/2009
2praeruptorin AIBA
04/2021 - 04/2020
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 01/2016
2Enhancer of Zeste Homolog 2 ProteinIBA
07/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2012
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2017 - 09/2014
2TubulinIBA
01/2016 - 06/2015
2DNA-Activated Protein KinaseIBA
06/2015 - 09/2012
2Phosphotransferases (Kinase)IBA
06/2015 - 04/2013
2Caspase 9IBA
06/2015 - 09/2014
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2014 - 01/2013
2Polysaccharides (Glycans)IBA
01/2014 - 01/2012
2Tyrosine Kinase InhibitorsIBA
11/2013 - 04/2011
2Lapatinib (GW572016)FDA Link
11/2013 - 04/2013
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2013 - 12/2006
2Epidermal Growth Factor (EGF)IBA
09/2010 - 07/2009
2butylidenephthalideIBA
02/2010 - 08/2008
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2021
1capsanthinIBA
01/2021
1Chemokine ReceptorsIBA
07/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2020
1salvianolic acid AIBA
04/2020
1anomalinIBA
04/2020
1praeruptorin CIBA
04/2020
1Hormones (Hormone)IBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1mangostinIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1LycopeneIBA
01/2020
1Succinic Acid (Succinate)IBA
03/2019
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2019
1Vitamin EFDA LinkGeneric
03/2019
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2019
1Sulfates (Sulfates, Inorganic)IBA
01/2019
1alpha-TocopherolFDA Link
01/2019
1Cyclin B1IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1aristolochic acid I (aristolochic acid)IBA
01/2018
1Polycomb Repressive Complex 2IBA
01/2018
1Complementary DNA (cDNA)IBA
01/2018
1BAY 11-7085IBA
01/2018
1Tissue Inhibitor of MetalloproteinasesIBA
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1Caspase 3 (Caspase-3)IBA
04/2017
1Mitogen-Activated Protein KinasesIBA
01/2017
1Vascular Endothelial Growth Factor CIBA
01/2017
1InflammasomesIBA
01/2017
1NicotineFDA Link
01/2017
1Environmental CarcinogensIBA
05/2016
1gallocatechol (epigallocatechin)IBA
03/2016
1sulforaphaneIBA
03/2016
1Checkpoint Kinase 1IBA
06/2015
1Checkpoint Kinase 2IBA
06/2015

Therapy/Procedure

10Therapeutics
01/2021 - 05/2009
5Immunotherapy
08/2021 - 05/2009
5Drug Therapy (Chemotherapy)
01/2020 - 08/2008
3Radiotherapy
07/2014 - 09/2012